Dr. Arshad Mohammad Khanani, MD

Dr. Khanani practices at Sierra Eye Associates in Reno, Nevada.

Dr. Khanani's NPI, 1295929511, was assigned on August 29, 2007. Dr. Khanani graduated from Texas Tech University Health Sciences Center School of Medicine in 2004. Dr. Khanani holds Nevada license 13420.

Dr. Khanani's primary practice is Sierra Eye Associates, at 950 Ryland St, Reno, NV 89502-1605. The practice phone is (775) 329-0286.

Dr. Khanani's primary practice is Sierra Eye Associates in Reno, Nevada. Dr. Khanani is also affiliated with Northern Nevada Medical Center. Dmand AI also links Dr. Khanani to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khanani practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Khanani's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Khanani is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Khanani's licenses on file in 2 states: Nevada and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, glaucoma, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Khanani treats.

CMS data shows 233,900 Medicare services from Dr. Khanani across 19 procedure codes in 2024, for 1,508 Medicare patients. Medicare paid $7,741,495 for them.

CMS counts 1,508 Medicare patients who saw Dr. Khanani in 2024. The largest group is 75 to 84, with 634 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Khanani's median patient age at 76, with 57% women.

In 2024, Dr. Khanani wrote 453 Medicare Part D claims for 168 patients. 50% of them were for generic drugs. CMS names the drug for 331 of them, across 9 drugs with 11 or more claims each, at $14,406 in total drug cost. In 2023, CMS named 425 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Khanani for performance year 2024, reported as part of a group. Dr. Khanani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 106 papers to Dr. Khanani, published from 2016 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Intravitreal Injections, Angiogenesis Inhibitors and Visual Acuity. Dr. Khanani has published most often in Am J Ophthalmol. Dr. Khanani's most frequent co-authors are Charles Clifton Wykoff, MD, PhD, Sunil S. Patel, MD, PhD and Carl Joshua Danzig, MD.

Dmand AI links Dr. Khanani to 5 clinical trials. Conditions studied include Macular Degeneration, Macular Edema and Diabetic Retinopathy. Recens Medical, Inc. sponsors the most, 2.

CMS Open Payments shows 1,810 general payments to Dr. Khanani from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Genentech, Inc. paid the most, $1,027,308. It also lists 98 research payments totaling $160,360 from 2020 to 2025.

Dmand AI lists 1 award for Dr. Khanani.

Dr. Khanani graduated from Texas Tech University Health Sciences Center School of Medicine in 2004. Dr. Khanani is a member of AAO.

Dr. Khanani is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.